230 related articles for article (PubMed ID: 33730878)
1. Changes in Buprenorphine Treatment After Medicaid Expansion.
Olfson M; Zhang VS; King M; Mojtabai R
Psychiatr Serv; 2021 Jun; 72(6):633-640. PubMed ID: 33730878
[TBL] [Abstract][Full Text] [Related]
2. Changes in Buprenorphine-Naloxone and Opioid Pain Reliever Prescriptions After the Affordable Care Act Medicaid Expansion.
Saloner B; Levin J; Chang HY; Jones C; Alexander GC
JAMA Netw Open; 2018 Aug; 1(4):e181588. PubMed ID: 30646116
[TBL] [Abstract][Full Text] [Related]
3. Prescription Drug Utilization and Reimbursement Increased Following State Medicaid Expansion in 2014.
Mahendraratnam N; Dusetzina SB; Farley JF
J Manag Care Spec Pharm; 2017 Mar; 23(3):355-363. PubMed ID: 28230452
[TBL] [Abstract][Full Text] [Related]
4. Impact of Medicaid expansion and state-level racial diversity on breast cancer endocrine therapy prescriptions: A quasi-experimental, comparative interrupted time series study.
Li C; Najarian M; Halpern MT
J Cancer Policy; 2022 Mar; 31():100317. PubMed ID: 35559873
[TBL] [Abstract][Full Text] [Related]
5. The effect of Medicaid expansion on state-level utilization of buprenorphine for opioid use disorder in the United States.
Knudsen HK; Hartman J; Walsh SL
Drug Alcohol Depend; 2022 Mar; 232():109336. PubMed ID: 35123365
[TBL] [Abstract][Full Text] [Related]
6. Association of the Affordable Care Act's Medicaid Expansion With Care Quality and Outcomes for Low-Income Patients Hospitalized With Heart Failure.
Wadhera RK; Joynt Maddox KE; Fonarow GC; Zhao X; Heidenreich PA; DeVore AD; Matsouaka RA; Hernandez AF; Yancy CW; Bhatt DL
Circ Cardiovasc Qual Outcomes; 2018 Jul; 11(7):e004729. PubMed ID: 29946015
[TBL] [Abstract][Full Text] [Related]
7. Impact of Medicaid Expansion on Medicaid-covered Utilization of Buprenorphine for Opioid Use Disorder Treatment.
Wen H; Hockenberry JM; Borders TF; Druss BG
Med Care; 2017 Apr; 55(4):336-341. PubMed ID: 28296674
[TBL] [Abstract][Full Text] [Related]
8. The effect of Medicaid expansion on use of opioid agonist treatment and the role of provider capacity constraints.
Gertner AK; Robertson AG; Jones H; Powell BJ; Silberman P; Domino ME
Health Serv Res; 2020 Jun; 55(3):383-392. PubMed ID: 32166761
[TBL] [Abstract][Full Text] [Related]
9. Buprenorphine Use Trends Following Removal of Prior Authorization Policies for the Treatment of Opioid Use Disorder in 2 State Medicaid Programs.
Keshwani S; Maguire M; Goodin A; Lo-Ciganic WH; Wilson DL; Hincapie-Castillo JM
JAMA Health Forum; 2022 Jun; 3(6):e221757. PubMed ID: 35977240
[TBL] [Abstract][Full Text] [Related]
10. Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees.
Wen H; Hockenberry JM; Pollack HA
JAMA Netw Open; 2018 Sep; 1(5):e182943. PubMed ID: 30646185
[TBL] [Abstract][Full Text] [Related]
11. States' implementation of the Affordable Care Act and the supply of physicians waivered to prescribe buprenorphine for opioid dependence.
Knudsen HK; Lofwall MR; Havens JR; Walsh SL
Drug Alcohol Depend; 2015 Dec; 157():36-43. PubMed ID: 26483356
[TBL] [Abstract][Full Text] [Related]
12. The effect of Medicaid expansion on prescriptions for breast cancer hormonal therapy medications.
Maclean JC; Halpern MT; Hill SC; Pesko MF
Health Serv Res; 2020 Jun; 55(3):399-410. PubMed ID: 32301119
[TBL] [Abstract][Full Text] [Related]
13. Differences in medicaid expansion effects on buprenorphine treatment utilization by county rurality and income: A pharmacy data claims analysis from 2009-2018.
Golan OK; Sheng F; Dick AW; Sorbero M; Whitaker DJ; Andraka-Christou B; Pigott T; Gordon AJ; Stein BD
Drug Alcohol Depend Rep; 2023 Dec; 9():100193. PubMed ID: 37876376
[TBL] [Abstract][Full Text] [Related]
14. Subsequent Buprenorphine Treatment Following Emergency Physician Buprenorphine Prescription Fills: A National Assessment 2019 to 2020.
Stein BD; Saloner B; Kerber R; Sorbero M; Gordon AJ
Ann Emerg Med; 2022 May; 79(5):441-450. PubMed ID: 35305851
[TBL] [Abstract][Full Text] [Related]
15. Medicaid expansion and opioid supply policies to address the opioid overdose crisis.
Shakya S; Harris SJ
Drug Alcohol Depend Rep; 2022 Jun; 3():100042. PubMed ID: 36845983
[No Abstract] [Full Text] [Related]
16. Association between state Medicaid expansion status and naloxone prescription dispensing.
Sohn M; Talbert JC; Delcher C; Hankosky ER; Lofwall MR; Freeman PR
Health Serv Res; 2020 Apr; 55(2):239-248. PubMed ID: 32030751
[TBL] [Abstract][Full Text] [Related]
17. Decline in Buprenorphine/Naloxone Prescriptions in a State Medicaid Population Following Formulary Conversion from Suboxone to Bunavail.
Soper R; Appajosyula S; Deximo C
Adv Ther; 2018 Apr; 35(4):457-466. PubMed ID: 29623562
[TBL] [Abstract][Full Text] [Related]
18. Trends in Buprenorphine to Treat Opioid Use Disorder in California, 2012 to 2018: Medicaid Outpaces the Rest of the State.
Tseregounis IE; Gasper JJ; Henry SG
J Addict Med; 2021 Sep-Oct 01; 15(5):425-428. PubMed ID: 33186262
[TBL] [Abstract][Full Text] [Related]
19. Medicaid Expansion and Utilization of Antihyperglycemic Therapies.
Sumarsono A; Buckley LF; Machado SR; Wadhera RK; Warraich HJ; Desai RJ; Everett BM; McGuire DK; Fonarow GC; Butler J; Pandey A; Vaduganathan M
Diabetes Care; 2020 Nov; 43(11):2684-2690. PubMed ID: 32887711
[TBL] [Abstract][Full Text] [Related]
20. Association of Medicaid Expansion Under the Affordable Care Act With Breast Cancer Stage at Diagnosis.
Le Blanc JM; Heller DR; Friedrich A; Lannin DR; Park TS
JAMA Surg; 2020 Aug; 155(8):752-758. PubMed ID: 32609338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
